Granted Patent B2

US 12,428,577 · App. 18/560,444 · Granted Sep 30, 2025

Inventor: Elliott Schmitt (Cambridge, MA)

Assignee: ModernaTX, Inc.

C09D133/08C08K3/34C09D5/14C09D7/61C09D175/04C12Q1/6851C12Q1/6865

Abstract

Claims (38)

1. A method comprising the steps of:

a) performing in vitro transcription of mRNA;

b) acquiring one or more Raman spectra during in vitro transcription of mRNA;

c) determining whether the in vitro transcription has reached a desired endpoint, whether the in vitro transcription is progressing at a desired rate, and/or whether one or more reaction conditions are as desired; and

d) modifying one or more reaction conditions after the determining step.

2. The method of claim 1 , wherein the method further comprises monitoring one or more reaction conditions and/or progression of the in vitro transcription.

3. The method of claim 1 , wherein the modifying one or more reaction conditions increases rate of reaction, increases yield, and/or reduces mRNA degradation.

4. The method of claim 1 , further comprising (e) stopping the in vitro transcription after the determining step.

5. The method of claim 1 , wherein the method comprises using greater than or equal to 1 probe for Raman spectroscopy and less than or equal to 10 probes for Raman spectroscopy.

6. The method of claim 1 , wherein the in vitro mRNA transcription comprises a batch process, a fed-batch process, and/or a continuous process.

7. The method of claim 1 , wherein the method further comprises monitoring whether all desired components of the in vitro transcription are present.

8. The method of claim 1 , wherein the method further comprises performing and/or monitoring one or more post-in vitro transcription processes.

9. The method of claim 8 , wherein the method comprises performing and monitoring one or more post-in vitro transcription processes, wherein the monitoring one or more post-in vitro transcription processes comprises monitoring the presence and/or concentration of one or more components of in vitro transcription during the post-in vitro transcription process.

10. A method comprising the steps of:

a) performing in vitro transcription of mRNA;

b) acquiring one or more Raman spectra during the in vitro transcription of mRNA;

c) monitoring one or more reaction conditions and/or progression of the in vitro transcription; and

d) optimizing one of more reaction conditions of a subsequent batch of in vitro transcription based on data generated from the monitoring step.

11. The method of claim 10 , wherein the method further comprises determining whether the in vitro transcription has reached a desired endpoint, whether the in vitro transcription is progressing at a desired rate, and/or whether one or more reaction conditions are as desired.

12. The method of claim 10 , wherein the one or more reaction conditions comprises temperature, concentration of one or more reactants, concentration of one or more components of one or more enzyme solutions, concentration of one or more components of one or more buffer solutions, and/or rate of mixing.

13. The method of claim 10 , wherein the monitoring comprises monitoring formation of one or more byproducts.

14. The method of claim 10 , wherein the monitoring comprises monitoring formation of orthophosphate.

15. The method of claim 10 , wherein the monitoring comprises monitoring reduction in concentration of one or more reactants.

16. The method of claim 10 , wherein the monitoring comprises monitoring reduction in concentration of one or more nucleoside triphosphates (NTPs).

17. The method of claim 10 , wherein the monitoring comprises monitoring one or more full Raman spectra.

18. The method of claim 10 , wherein the monitoring comprises monitoring one or more peaks of one or more Raman spectra.

19. The method of claim 10 , wherein the monitoring comprises monitoring one or more peaks at greater than or equal to 970 cm −1 and less than or equal to 1000 cm 1 of one or more Raman spectra.

20. The method of claim 10 , wherein the monitoring comprises monitoring one or more peaks at greater than or equal to 1100 cm −1 and less than or equal to 1120 cm −1 of one or more Raman spectra.

21. The method of claim 10 , wherein the monitoring comprises monitoring one or more peaks at greater than or equal to 1150 cm −1 and less than or equal to 1650 cm −1 of one or more Raman spectra.

22. The method of claim 10 , wherein the monitoring comprises monitoring one or more peaks at greater than or equal to 800 cm −1 and less than or equal to 880 cm −1 of one or more Raman spectra.

23. The method of claim 10 , wherein the monitoring comprises monitoring one or more peaks at greater than or equal to 920 cm −1 and less than or equal to 940 cm −1 of one or more Raman spectra.

24. The method of claim 10 , wherein the monitoring comprises monitoring one or more peaks at greater than or equal to 1040 cm −1 and less than or equal to 1070 cm −1 of one or more Raman spectra.

25. The method of claim 10 , wherein the monitoring comprises using an algorithm to determine whether the in vitro transcription has reached a desired endpoint, whether the in vitro transcription is progressing at a desired rate, and/or whether one or more reaction conditions are as desired.

26. The method of claim 25 , wherein the algorithm comprises Principal Component Analysis (PCA) and/or a Batch Evolution Model.

27. The method of claim 10 , wherein the monitoring comprises comparing one or more Raman spectra and/or representations thereof to one or more reference Raman spectra and/or representations thereof to identify the presence of one or more differences.

28. The method of claim 27 , wherein the method further comprises identifying the cause of the one or more differences that are present.

29. The method of claim 10 , wherein the monitoring comprises monitoring a peak representative of mRNA.

30. The method of claim 10 , wherein the method comprises using greater than or equal to 1 probe for Raman spectroscopy and less than or equal to 10 probes for Raman spectroscopy.

Assignments (2)

Continuity (2)

References Cited (335)